FDA PMA FDA Class 2 Approved 🇺🇸 United States

Catheters, Transluminal Coronary Angioplasty, Percutaneous

PMA: P810046 · Supplement: S185 · Decision Jun 8, 1998
Classifications
1
FEI Numbers
70
Registration Numbers
70

Basic Information

Device Name
Catheters, Transluminal Coronary Angioplasty, Percutaneous
Trade Name
ACS RX COMET VP (TM) CORONARY DILATATION CATHETER/HYDROCOAT HYDROPHILIC
PMA Number
P810046
Supplement Number
S185
Device Class
FDA Class 2
Product Code
LOX
Generic Name
Catheters, transluminal coronary angioplasty, percutaneous
Regulation Number
870.5100
Medical Specialty
Cardiovascular
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
June 8, 1998
Date Received
January 20, 1998
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for an additional balloon length, the addition of HYDROCOAT(TM) hydrophilic coating, a change in the sterilization method and hydrophilic coating, a change in the sterilization method and hydrophilic coating, a change in the sterilization method and packaging and an increase in the rated ubrst pressure for the 3.25mm through 4.0mm balloon diameters. The device as modified, will be marketed under the trade name ACS RX Comet VP(TM) Coronary Dilatation Catheters with HYDROCOAT(TM) Hydrophilic coating and is indicated for: 1)balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improvng myocardial perfusion; and 2) balloon dilatation of a coronary artery occlusion for the purose of restoring coronary flow in patients with ST-segment elevation yocardial infarction.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous